已收录 272442 条政策
 政策提纲
  • 暂无提纲
Investigation into the production of a particle-in-particle system for the treatment of hepatocellular carcinoma by transarterial chemoembolization
[摘要] Transarterial Chemoembolization (TACE) is a leading therapy in patients suffering from intermediate hepatocellular carcinoma (HCC).TACE is a transarterial therapy that involves injection of particles and chemotherapeutic agents to the tumour site.Once administrated, the particles block the blood flow to the tumour while also allowing targeted delivery.Several therapies have proven to increase survival in people suffering from HCC where drug eluting beads (DEBs) have become a frequently used method.Despite their success, DEBs are limited to drugs that interact with the embolizing material’s functional groups.Also, the embolizing beads must be calibrated to a patient’s blood vessel size where smaller sized beads will display faster release rates.In order to overcome these disadvantages, a Particle-in-Particle (PIP) system is proposed.Small microparticles (1 – 3 µm) are to be manufactured to suit a specific drug where they will function as a drug delivery component.These microparticles are then to be encapsulated into larger microparticles (100 – 1000 µm) which will act as an embolizing component of the PIP system.Polymers and particle production methods are to be investigated in order to produce a PIP system capable of targeted delivery of a wider class of drugs with identical release rates.
[发布日期]  [发布机构] University:University of Birmingham;Department:School of Chemical Engineering
[效力级别]  [学科分类] 
[关键词] R Medicine;RC Internal medicine;RC0254 Neoplasms. Tumors. Oncology (including Cancer) [时效性] 
   浏览次数:6      统一登录查看全文      激活码登录查看全文